Investigations of the Effects of Aprovel, Lipanor and Their Combination Onto the Endothelial Functions of Dyslipidemic Patients Measure by Laser Doppler Flow-Metry.

Trial Profile

Investigations of the Effects of Aprovel, Lipanor and Their Combination Onto the Endothelial Functions of Dyslipidemic Patients Measure by Laser Doppler Flow-Metry.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2007

At a glance

  • Drugs Ciprofibrate; Irbesartan
  • Indications Dyslipidaemias; Hypertension
  • Focus Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 17 Sep 2007 Status changed from in progress to completed.
    • 12 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top